|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/44 | (2006.01) |
| A61P 27/02 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 9/08 | (2006.01) |
| (11) | Number of the document | 3291812 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16790066.1 |
| Date of filing the European patent application | 2016-05-05 | |
| (97) | Date of publication of the European application | 2018-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/030912 |
| Date | 2016-05-05 |
| (87) | Number | WO 2016/179357 |
| Date | 2016-11-10 |
| (30) | Number | Date | Country code |
| 201562157257 P | 2015-05-05 | US |
| (72) |
ASHTON, Paul , US
|
| (73) |
EyePoint Pharmaceuticals US, Inc. ,
400 Pleasant Street, Watertown, MA 02472,
US
|
| (54) | INJECTABLE DEPOT FORMULATIONS |
| INJECTABLE DEPOT FORMULATIONS |